Dr. Lawrence Wechsler gives a presentation on Cerebrovascular disease, which is the 5th leading cause of death. Strokes are the leading cause of disability in adults.

Educational objectives:

Upon completion of this activity, participants should be able to:

  • Improve clinical decision making and knowledge related to anti platelet use after ischemic stroke or high risk TIA
  • Demonstrate knowledge of patient selection for mechanical thrombectomy in large vessel occlusion
  • Apply knowledge of time sensitivity in IV tPA initiation to improve clinical outcomes after ischemic stroke

Reading Resources: 

  1.  Powers WJ, Derdeyn CP, Biller J, Coffey, CS, Hoh BL, Jauch EC, Johnson SC, Khalessi AA, Kidwell, CS, Meschia FM, Ovbiagele B, Yavagal DR on behalf of the AHA stroke council. 2015 AHA/ASA focused update of the 2013 Guidelines for the Early Management of patients with Acute Ischemic Stroke regarding endovascular treatment. Stroke. 2015; 46:3020-3035
  2. Yongjun Wang, M.D., Yilong Wang, M.D., Ph.D., Xingquan Zhao, M.D., Ph.D., Liping Liu, M.D., Ph.D., David Wang, D.O., F.A.H.A., F.A.A.N., et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.  N Engl J Med 2013; 369:11-19July 4, 2013DOI: 10.1056/NEJMoa1215340
  3. Jauch EC, Saver JL, Adams HP, Bruno A, Connors JJ, Demaershalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals form the American Heart Association/American Stroke Association. Stroke. 2013; 44: 870-947
  4. Damaerschalk BM, Kleindorfer DO, Adeoye OM, Demchuk AM, Fugate JE, & Grotta JC, et al. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke:  a statement for healthcare professionals from the American Heart Association/American Stroke Association. 2016; Stroke; 47: 581-641

Disclosures:

Dr. Wechsler has financial interests with the following any entity or entities producing health care goods or services as indicated below:

  • Consultant: Biogen Idec, San Bio, Athersys
  • Scientific Advisory Board:  Silk Road Med, Remedy Pharm, Forest Devices; Steering Committee, ACT I

All presenters disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above.  No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Accreditation Statement: 

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.75) continuing education units (CEU) which are equivalent to .75 contact hour.

For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.com and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.

Release Date: 10/27/2017 | Last Modified On: 10/27/2017 | Expires: 10/29/2018

 

take cme evaluation